Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingre Jiedu Capsule is a Traditional Chinese Medicine (TCM) product developed and manufactured by Shanxi Buchang Pharmaceutical. It is formulated based on the traditional principle of 'clearing heat and detoxifying' (Qingre Jiedu), which is used to address internal heat, inflammation, and toxic accumulation. The capsule is primarily indicated for the treatment of respiratory tract infections and associated fever. As a multi-herb formulation, it typically contains extracts from plants such as Lonicera japonica (honeysuckle) and Forsythia suspensa, which are traditionally recognized for their broad-spectrum antimicrobial and anti-inflammatory properties. It is an approved pharmaceutical product in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingre Jiedu Capsule.